ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Cantourage Group SE's annualizedNet Income for the quarter that ended in Jun. 2025 was €0.07 Mil.
Cantourage Group SE's average Total Assets over the quarter that ended in Jun. 2025 was €45.48 Mil. Therefore, Cantourage Group SE's annualized ROA % for the quarter that ended in Jun. 2025 was 0.16%.
The historical rank and industry rank for Cantourage Group SE's ROA % or its related term are showing as below:
XTER:HIGH'
s ROA % Range Over the Past 10 Years
Min: -41.73 Med: -17.1 Max: 0.08
Current: 0.08
During the past 5 years, Cantourage Group SE's highest ROA % was 0.08%. The lowest was -41.73%. And the median was -17.10%.
XTER:HIGH's ROA % is ranked worse than 63.12% of 1006
companies
in the Drug Manufacturers industry
Industry Median: 2.685
vs XTER:HIGH: 0.08
Cantourage Group SE (XTER:HIGH) ROA % Explanation
ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A banks ROA % is typically well under 2%.
Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:
Note:
The Net Income data used here is two times the semi-annual (Jun. 2025) net income data. The Revenue data used here is two times the semi-annual (Jun. 2025) revenue data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.
E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.
Cantourage Group SE ROA % Related Terms
Cantourage Group SE ROA % Historical Data
* Premium members only.
The historical data trend for Cantourage Group SE's ROA % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Cantourage Group SE's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cantourage Group SE ROA % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Cantourage Group SE's ROA % distribution charts can be found below:
* The bar in red indicates where Cantourage Group SE's ROA % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is two times the semi-annual (Jun. 2025) net income data.
ROA % is displayed in the 30-year financial page.
Cantourage Group SE (XTER:HIGH) has a ROA % of 0.16% as of Jun. 2025. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Cantourage Group SE and its competitors. According to the industry distribution chart, Cantourage Group SE ranks #635 out of 1006 companies in the Drug Manufacturers industry, placing it in the top 63.1%.
Is Cantourage Group SE's ROA % too high?
Cantourage Group SE's current ROA % is 0.16%. The Drug Manufacturers industry median ROA % is 2.69. Cantourage Group SE's value of 0.16% is 94% below this industry median. Based on the distribution chart, Cantourage Group SE ranks #635 out of 1006 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Cantourage Group SE has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does Cantourage Group SE's ROA % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Cantourage Group SE ranks #635 out of 1006 companies for ROA %. This places Cantourage Group SE in the lower half of its industry. The industry median ROA % is 2.69. Cantourage Group SE's value of 0.16% is 94% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROA % for a Drug Manufacturers company?
The median ROA % among Drug Manufacturers companies is 2.69, based on 1,006 companies in the industry. Companies in the top quartile (top 25%) have a ROA % significantly above this median, while those in the bottom quartile fall well below. However, ROA % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cantourage Group SE's current ROA % of 0.16% is 94% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROA % mean?
A high ROA % can signal that a stock is expensive relative to its fundamentals. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Cantourage Group SE and its competitors. For the Drug Manufacturers industry, the median ROA % is 2.69 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cantourage Group SE's current ROA % is 0.16%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cantourage Group SE stock overvalued right now?
Cantourage Group SE (XTER:HIGH) has a current ROA % of 0.16%. The current ROA % is 0.16% and 94% below the Drug Manufacturers industry median of 2.69. Cantourage Group SE's overall GF Score™ is 22/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROA % calculated?
ROA % is calculated from a company's financial statements. For Cantourage Group SE (XTER:HIGH), the current ROA % is 0.16% as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Cantourage Group SE is engaged in the manufacture and wholesale of medicinal preparations based on cannabis and the trade and distribution of other legally permissible cannabis products, medical devices, pharmaceuticals, and accessories. The group offers cannabis flowers, dronabinol, CBD, and extracts of various strains.
22GF Score
Get the complete analysis for XTER:HIGH
ROA % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XTER:HIGH has been successfully added to your 
